Shionogi – GARDP, Cefiderocol License Agreement

• Post author:GHIAA Admin
• Post published:July 8, 2022
• Post category:

Continue ReadingShionogi – GARDP, Cefiderocol License Agreement

NIH – MPP, COVID-19 Patent and Biological Material License Agreement

• Post author:GHIAA Admin
• Post published:June 29, 2022
• Post category:

Continue ReadingNIH – MPP, COVID-19 Patent and Biological Material License Agreement

CSIC-MPP, COVID-19 Antibody Diagnostic, Patent & Material License Agreement

• Post author:GHIAA Admin
• Post published:May 23, 2022
• Post category:

Continue ReadingCSIC-MPP, COVID-19 Antibody Diagnostic, Patent & Material License Agreement

Merck – MPP, Molnupiravir License Agreement

• Post author:GHIAA Admin
• Post published:November 22, 2021
• Post category:

Continue ReadingMerck – MPP, Molnupiravir License Agreement

MPP – University of Liverpool, Solid Drug Nanoparticle Technology License Agreement

• Post author:GHIAA Editor
• Post published:May 21, 2020
• Post category:

Continue ReadingMPP – University of Liverpool, Solid Drug Nanoparticle Technology License Agreement